| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.25 | 9e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |